AEK-5764749-5/11/1

Novo Nordisk A/S - G8, X9 M.FI — FEI 3003037054

Refusal Details

Date
November 9, 2024
Country
Denmark
Product Category
Drugs and Biologics
Product Code
61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
75